Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.
about
Controversial aspects of thyroid disease.Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.Outcome of thyroid associated ophthalmopathy treated by radiation therapyImpact of smoking on the response to treatment of thyroid associated ophthalmopathy.Graves' ophthalmopathy: a review of immunogenetics.Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment
P2860
Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@en
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@nl
type
label
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@en
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@nl
prefLabel
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@en
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@nl
P2093
P356
P1476
Soluble interleukin-1 receptor ...... dergoing orbital radiotherapy.
@en
P2093
Heufelder AE
Heufelder G
Hofbauer LC
Mühlberg T
Schworm HD
P304
P356
10.1210/JCEM.82.7.4068
P407
P577
1997-07-01T00:00:00Z